Round 1 Winners!
Proof of Usefulness Report

Neurosnap Inc.

Analysis completed on 3/16/2026

+51.67
Proof of Usefulness Score
You're In Business

Neurosnap offers high real-world utility and technical innovation by making AlphaFold2 and bio-ML tools accessible. However, the submission suffers from hyperbolic and unsupported claims regarding traction ('most people have used my product') and audience reach ('everyone'). The claimed $2.5M market cap and 30-person team suggest some real-world footprint, but the lack of concrete active user or revenue metrics severely limits the evidence of traction score, placing it in the minimal verified traction category.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+21.25
Audience Reach Impact+1.50
Technical Innovation+12.00
Evidence Of Traction+2.50
Market Timing Relevance+8.50
Functional Completeness+0.38
Subtotal+46.13
Usefulness Multiplierx1.12
Final Score+52

Project Details

Project URL
Description
Tools like AlphaFold2 have revolutionized the way we biologists do our research, but unfortunately accessing them isn't always that straightforward. Neurosnap is a fully end-to-end suite of machine learning tools designed to easily integrate into your synthetic biology, pharmaceutical, and medical pipelines.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline